KRAS mutations affect prognosis of non-small-cell lung cancer patients treated with first-line platinum containing chemotherapy

KRAS mutations seem to indicate a poor outcome in Non-Small-Cell Lung Cancer (NSCLC) but such evidence is still debated. The aim of this planned ancillary study within the TAILOR trial was to assess the prognostic value of KRAS mutations in advanced NSCLC patients treated with platinum-based first-l...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Marabese, Mirko, Ganzinelli, Monica, Garassino, Marina C., Shepherd, Frances A., Piva, Sheila, Caiola, Elisa, Macerelli, Marianna, Bettini, Anna, Lauricella, Calogero, Floriani, Irene, Farina, Gabriella, Longo, Flavia, Bonomi, Lucia, Fabbri, M. Agnese, Veronese, Silvio, Marsoni, Silvia, Broggini, Massimo, Rulli, Eliana
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2015
Assuntos:
Clinical Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4741822/
https://ncbi.nlm.nih.gov/pubmed/26416458
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados